angiotensin ii has been researched along with ramipril in 126 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (20.63) | 18.7374 |
1990's | 45 (35.71) | 18.2507 |
2000's | 41 (32.54) | 29.6817 |
2010's | 10 (7.94) | 24.3611 |
2020's | 4 (3.17) | 2.80 |
Authors | Studies |
---|---|
Brockmeier, D; Heintz, B; Kierdorf, H; Kirsten, R; Lückel, G; Maigatter, S; Nelson, K; Rangoonwala, B; Sieberth, HG; Verho, M | 1 |
Carretero, OA; Farhy, RD; Ho, KL; Scicli, AG | 1 |
Huysmans, FT; Koene, RA; Sluiter, HE; van Hamersvelt, HW; Wetzels, JF | 1 |
Jahnecke, C; Kappes-Horn, K; Kramer, HJ; Meyer-Lehnert, H | 1 |
Akbary, A; Chen-Gal, B; Erman, A; Levi, E; Rabinov, M; Rosenfeld, JB; Shmueli, J; Tadjer, S; Winkler, J; Zelykovski, A | 1 |
Benetos, A; Safar, M; Thiéry, P; Vasmant, D | 1 |
Blöchl, A; Dominiak, P | 2 |
Henning, R; Linz, W; Schölkens, BA | 1 |
Goodman, SA; Gould, AB | 1 |
Iimura, O; Nakagawa, M; Shimamoto, K | 1 |
Bönner, G; Danckwardt, L; Rettig, R; Shimizu, I; Unger, T | 1 |
Hayashi, S; Izumi, H | 1 |
Collier, JG; Webb, DJ | 2 |
Kimura, B; Phillips, MI | 1 |
Debusmann, ER; Grötsch, H; Irmisch, R; Jane, F; Lahn, W; Mora, J; Ocón-Pujadas, J | 1 |
Iimura, O; Shimamoto, K | 2 |
Ehmke, H; Kirchheim, H; Kögler, U; Persson, PB | 1 |
Ganten, D; Linz, W; Schölkens, BA | 1 |
Craig, K; MacDonald, TM; Watson, ML | 1 |
Albus, U; Just, M; Kaiser, J; Linz, W; Petry, P; Qi, BY; Schölkens, BA | 1 |
Brunner, HR; Nussberger, J; Waeber, B | 1 |
Abrahamsson, T; Carlsson, L | 1 |
Fregly, MJ; Rowland, NE | 1 |
Bührle, CP; Rosivall, L; Taugner, R | 1 |
Ganten, D; Jin, M; Lang, RE; Lindpaintner, K; Schoelkens, BA; Unger, T; Wilhelm, MJ | 1 |
Giesen-Crouse, E; Imbs, JL; Krieger, JP; Schmidt, M; Welsch, C | 1 |
Bayer, C; Ganten, D; Hermann, K; Lang, RE; Unger, T | 1 |
Brigden, GS; Caruana, MP; Heber, ME; Lahiri, A; Raftery, EB | 1 |
Vierhapper, H; Waldhäusl, W; Witte, PU | 1 |
Ball, SG; Leckie, BJ; Malatino, LS; Manhem, P; Morton, JJ; Murray, GD; Robertson, JI | 1 |
Ganten, D; Lang, RE; Moursi, MG; Unger, T | 1 |
Adams, FG; Gillen, G; Morton, JJ; Robertson, JI; Tillman, DM | 1 |
Han, YF; Linz, W; Schölkens, BA | 1 |
Kimura, BK; Phillips, MI | 1 |
Schacht, U | 1 |
Berkenboom, G; Brékine, D; Fontaine, J; Gulbis, B; Unger, P | 1 |
Traub, O; Watts, SW; Webb, RC | 1 |
Hartman, JC | 1 |
Hamann, M; Hegyi, I; Kaissling, B; Kurtz, A; Schricker, K | 1 |
Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 1 |
Amtorp, O; Gundersen, T; Nilsson, B; Remes, J; Sigurdsson, A; Swedberg, K | 1 |
Carlyle, PF; Cohn, JN; Francis, GS; Garr, M; Hauer, K; Hunter, DW; McDonald, KM; Parish, T; Stillman, A | 1 |
Sigurdsson, A; Swedberg, K; Ullman, B | 1 |
Hamann, M; Holmer, S; Kurtz, A; Riegger, G; Schricker, K | 1 |
Allan, DR; Coletti, CM; Hollenberg, NK; Kifor, I; McKnight, JA | 1 |
McDaniel, PA; Riddle, MC | 1 |
Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G | 1 |
Brasch, H; Dominiak, P; Sieroslawski, L | 1 |
Flood, JF; Morley, JE | 1 |
Chatterjee, K; Ives, HE; Sudhir, K; Wilson, E | 1 |
Finta, KM; Fischer, MJ; Gordon, D; Lee, L; Pitt, B; Webb, RC | 1 |
Campbell, DJ; Duncan, AM; Kladis, A | 1 |
Hartman, JC; Hullinger, TG; Shebuski, RJ; Wall, TM | 1 |
Lloyd, MC; Traub, O; Webb, RC | 1 |
Cachofeiro, V; Guan, H; Kaminski, PM; Nasjletti, A; Pucci, ML; Wolin, MS | 1 |
DiPette, DJ; Wang, DH; Yao, A; Zhao, H | 1 |
Bauer, JH; Campbell, F; Knaus, J; Reams, G; Weaver-Osterholtz, D; Wu, Z | 1 |
Campagnole-Santos, MJ; Fontes, MA; Khosla, MC; Lima, DX; Oliveira, RC; Santos, RA | 1 |
Dunham, EW; Zhang, X; Zimmerman, BG | 1 |
Barthelmebs, M; Grima, M; Imbs, J; Stephan, D; Vasmant, D; Welsch, M | 1 |
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD | 1 |
Dam, JP; Porsius, AJ; Post, MJ; Riezebos, J; Vleeming, W; Wemer, J | 1 |
Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S | 1 |
Barthelmebs, M; Grima, M; Imbs, JL; Ingert, C; Michel, B | 1 |
Bech, JN; Hansen, HE; Jensen, KT; Kornerup, HJ; Nielsen, CB; Pedersen, EB; Spencer, ES; Sølling, J | 1 |
Bock, P | 1 |
Aalto, M; Grönroos, PE; Irjala, KM; Kantola, IM; Matinlauri, IH; Vesalainen, RK | 1 |
Bohlender, J; Dietz, R; Haass, M; Höhnel, K; Luft, FC; Scheuermann, M; Thibault, G; Willenbrock, R | 1 |
Jamerson, KA | 1 |
Deutsch, P; Ianosi-Irimie, M | 1 |
Cooper, ME; Gilbert, RE; Huang, XR; Johnson, RJ; Lai, KN; Lan, HY; Wu, LL; Yang, N; Yu, XQ | 1 |
Bulagannawar, M; Carretero, OA; Cavasin, MA; Karumanchi, R; Liu, YH; Mehta, D; Yang, XP | 1 |
Cooper, ME; Cox, AJ; Gilbert, RE; Hendrich, EC; Jerums, G; Kelly, DJ; Lee, V; Osicka, T; Panagiotopoulos, S; Rumble, JR; Wilkinson-Berka, JL | 1 |
Johnson, RJ; Lombardi, DM; Saavedra, JM; Schwartz, SM; Vio, CP; Viswanathan, M | 1 |
Kurtz, A; Müller, M; Todorov, V | 1 |
Schuitheiss, HP; Tschöpe, C; Walther, T | 1 |
Adam, A; Gagnon, C; Gosselin, H; Kapuku, G; Lambert, C; Meloche, S; Pelletier, S; Rouleau, JL | 1 |
Ajani, U; Arnold, M; Glynn, R; Greaves, S; Hall, C; Harel, F; Hennekens, C; Pfeffer, M; Rouleau, JL; Sirois, P; Solomon, S; White, M | 1 |
Ditiatkov, AE; Radzevich, AE; Tikhonov, VA | 1 |
Ehmke, H; Just, A; Kirchheim, HR; Wittmann, U | 1 |
Emanueli, C; Gaspa, L; Maddeddu, P; Madeddu, P; Pinna, A; Salis, MB; Stacca, T | 1 |
Abbas, A; Brown, NJ; Byrne, D; Schoenhard, JA; Vaughan, DE | 1 |
Agabiti-Rosei, E; Bova, S; Neri, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP; Sacchetto, A | 1 |
Agabiti-Rosei, E; Bova, S; Cavallin, M; Mazzocchi, G; Nussdorfer, GG; Pessina, AC; Rizzoni, D; Rossi, GP | 1 |
Hankey, GJ | 1 |
Bottoms, SE; Chambers, RC; Gohlke, P; Howell, DC; Laurent, GJ; Marshall, RP; McAnulty, RJ; Unger, T | 1 |
Unger, T | 1 |
Avila-Casado, Mdel C; Bautista, R; Escalante, B; Manning, R; Martinez, F; Medina, A; Soto, V | 1 |
Matos, L | 1 |
Critchley, J; Critchley, L; Ding, B; Fok, B; James, A; Thomas, GN; Tomlinson, B; Wang, D | 1 |
Aviram, M; Coleman, R; Hamoud, S; Hayek, T; Kaplan, M; Keidar, S; Pavlotzky, E | 1 |
Bandinelli, M; Boddi, M; Cecioni, I; Chiavarelli, M; Coppo, M; Lisi, GF; Modesti, PA; Neri Serneri, GG; Papa, ML; Toscano, T | 1 |
Unger, T; Zimmermann, M | 1 |
Iwasaka, T; Okigaki, M | 1 |
Luft, FC | 1 |
Avila-Casado, MC; Bautista, R; Coronel, I; Escalante, B; Romo, E; Soto, V; Vázquez, E; Villalón, CM | 1 |
Daniel, WG; Eskafi, S; Gabler, C; Garlichs, CD; Illmer, T; Lorenz, HM; Roerick, O; Schmeisser, A; Soehnlein, O; Strasser, R | 1 |
Bradbury, AW; Hobbs, SD; Thomas, ME | 1 |
Dendorfer, A; Dominiak, P; Raasch, W | 1 |
Ahn, YB; Cha, BY; Hong, OK; Jeong, IK; Kim, JW; Kim, MJ; Ko, SH; Son, HY; Song, KH; Yoon, KH | 1 |
Dendorfer, A; Dodt, C; Dominiak, P; Jöhren, O; Pahlke, F; Raasch, W; Voges, I; Wittmershaus, C | 1 |
Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM | 1 |
Cai, W; Chen, JZ; Ruan, LM; Wang, YN | 1 |
Blaak, EE; Goossens, GH; Saris, WH; Schiffers, PM; van Baak, MA | 1 |
Ambühl, PM; Bachmann, MF; Fulurija, A; Jennings, GT; Maurer, P; Müller, P; Nief, V; Nussberger, J; Pfister, T; Rettenbacher, M; Roubicek, K; Sabat, R; Schellekens, C; Sladko, K; Tissot, AC; Volk, HD; Wagner, F | 1 |
Bobillier, A; Gardner, R; Hillier, C; MacFadyen, R; Mann, J; McDonagh, T; McMurray, J; Murdoch, D; Seed, A | 1 |
Adrahtas, A; Cantwell, DM; Kompa, AR; Krum, H; Lewis, DA; See, F; Wang, BH | 1 |
Schindler, C | 1 |
Araghi, A; Beierwaltes, WH; Doci, TM; Mattingly, R; Yingst, DR | 1 |
Angeli, F; Garofoli, M; Gentile, G; Martire, P; Mazzotta, G; Reboldi, G; Verdecchia, P | 1 |
Bieri, M; Farkas, A; Ligeti, N; Marti, HP; Meier, B; Mohacsi, P; Oroszlán, M | 1 |
Chung, IM; Kim, CK; Kim, YM; Shin, MK; Suh, SH; Yoo, MH | 1 |
Mitsuyama, S | 1 |
Arfa, O; Czech, T; Ebrahimian, T; Endtmann, C; Fritz, M; Laufs, U; Nickenig, G; Petoumenos, V; Wassmann, K; Wassmann, S; Werner, N | 1 |
Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
Ayuzawa, N; Fujita, T; Ishizawa, K; Kawarazaki, W; Nagase, M; Takeuchi, M; Ueda, K; Yoshida, S | 1 |
D'Angelo, A; Derosa, G; Fogari, R; Gualtierotti, R; Lazzari, P; Mugellini, A; Zoppi, A | 1 |
Butori, C; Esnault, VL; Favre, GA; Hofman, P; Lebrun, P; Lopez, P; Van Obberghen, E | 1 |
Bessaguet, F; Danigo, A; Demiot, C; Desmoulière, A; Magy, L; Sturtz, F | 1 |
Aluko, EO; Fasanmade, AA; Nna, VU | 1 |
Funder, JW | 1 |
Abouelkheir, M | 1 |
Alcalai, R; Arad, M; Guetta, T; Hochhauser, E; Kornowski, R; Ofek, E; Petrover, Z; Seidman, CE; Seidman, J; Yadin, D | 1 |
9 review(s) available for angiotensin ii and ramipril
Article | Year |
---|---|
In vivo concentrations of kinins and angiotensins.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Humans; Hypertension; Kinins; Radioimmunoassay; Ramipril | 1990 |
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black or African American; Black People; Blood Pressure; Blood Volume; Calcium Channel Blockers; Diet, Sodium-Restricted; Diuretics; Ethnicity; Humans; Hypertension; Ramipril; Renin; Risk Factors; United States | 2000 |
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Life Style; Practice Guidelines as Topic; Ramipril; Risk; Risk Factors; Stroke; Telmisartan | 2003 |
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Ramipril; Renin-Angiotensin System; Telmisartan | 2003 |
[New possibilities in clinical use of angiotensin II receptor inhibitors].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Heart Failure; Humans; Ramipril; Renin-Angiotensin System; Survival Analysis; Telmisartan; Treatment Outcome | 2003 |
[Involvement of angiotensin II in pathogenesis of hypertension and target organ damage].
Topics: Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Cardiomegaly; Clinical Trials as Topic; Coronary Restenosis; Humans; Hypertension; Hypertension, Renal; Insulin Resistance; Losartan; Ramipril; Receptor, Angiotensin, Type 1 | 2004 |
Manipulation of the renin angiotensin system in peripheral arterial disease.
Topics: Algorithms; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Humans; Peripheral Vascular Diseases; Ramipril; Renal Artery Obstruction; Renin-Angiotensin System | 2004 |
Aliskiren versus ramipril in hypertension.
Topics: Aging; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetic Angiopathies; Fumarates; Half-Life; Humans; Hypertension; Ramipril; Renin-Angiotensin System | 2010 |
20 trial(s) available for angiotensin ii and ramipril
Article | Year |
---|---|
Influence of ramipril on plasma atrial natriuretic peptide, antidiuretic hormone, angiotensin II and aldosterone in patients with chronic congestive heart failure.
Topics: Aged; Aged, 80 and over; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Radioimmunoassay; Ramipril; Sodium; Vasopressins | 1992 |
Is natriuresis on felodipine due to reversal of the renal effects of angiotensin II?
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Double-Blind Method; Felodipine; Humans; Kidney; Male; Natriuresis; Ramipril | 1992 |
Frusemide, ACE inhibition, renal dopamine and prostaglandins: acute interactions in normal man.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Dopamine; Drug Interactions; Electrolytes; Furosemide; Hemodynamics; Humans; Inulin; Kallikreins; Kidney; Male; p-Aminohippuric Acid; Prostaglandins E; Ramipril; Renal Circulation; Renin | 1989 |
First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Determination; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clinical Trials as Topic; Female; Humans; Hypertension; Male; Middle Aged; Monitoring, Physiologic; Ramipril; Time Factors | 1988 |
Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Drug Interactions; Humans; Male; Norepinephrine; Ramipril; Time Factors | 1986 |
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Prognosis; Ramipril; Time Factors | 1994 |
Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Hormones; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Ramipril | 1994 |
Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Topics: Aldosterone; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Potassium; Ramipril; Renin; Renin-Angiotensin System | 1996 |
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow | 1996 |
A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two yea
Topics: Adolescent; Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Endothelins; Felodipine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Placebos; Prospective Studies; Ramipril | 1997 |
Response of serum total renin to ramipril and metoprolol in hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Humans; Hypertension; Male; Metoprolol; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin | 1998 |
Changes in vasoconstrictive hormones, natriuretic peptides, and left ventricular remodeling soon after anterior myocardial infarction.
Topics: Angiotensin II; Atrial Natriuretic Factor; Biomarkers; Catecholamines; Dopamine; Double-Blind Method; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Norepinephrine; Ramipril; Stroke Volume; Ventricular Remodeling | 2001 |
Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Cross-Over Studies; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Ramipril; Renin; Single-Blind Method; Tissue Plasminogen Activator | 2002 |
Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chymases; Combined Modality Therapy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Cytokines; Female; Gene Expression Profiling; Humans; Male; Microcirculation; Middle Aged; Mitral Valve Stenosis; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Preoperative Care; Ramipril; Renin-Angiotensin System; RNA, Messenger; Serine Endopeptidases; Tetrazoles; Valine; Valsartan; Vasculitis | 2004 |
Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Germany; Heart Diseases; Humans; Hypertension; Prognosis; Ramipril; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Reduction Behavior; Telmisartan; Treatment Outcome | 2004 |
Effect of short-term ACE inhibitor treatment on peripheral insulin sensitivity in obese insulin-resistant subjects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood Pressure; Double-Blind Method; Fatty Acids, Nonesterified; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Placebos; Ramipril | 2006 |
A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibody Specificity; Antihypertensive Agents; Autoantibodies; Blood Pressure; Disease Models, Animal; Double-Blind Method; Drug Evaluation, Preclinical; Humans; Hypertension; Male; Mice; Mice, Inbred BALB C; Middle Aged; Patient Compliance; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Time Factors; Vaccines; Virion | 2007 |
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.
Topics: Aged; Aldosterone; Amides; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Female; Fumarates; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Ramipril; Renin; Statistics, Nonparametric; Treatment Outcome | 2007 |
Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Apoptosis; Benzimidazoles; Benzoates; Blood Vessels; Bone Marrow Transplantation; Cell Count; Cells, Cultured; Coronary Artery Disease; Double-Blind Method; Endothelial Cells; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Ramipril; Receptor, Angiotensin, Type 1; Regeneration; Stem Cells; Telmisartan; Vasoconstrictor Agents | 2011 |
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albumins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazolidines; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Ramipril; Treatment Outcome | 2013 |
97 other study(ies) available for angiotensin ii and ramipril
Article | Year |
---|---|
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bridged Bicyclo Compounds; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Imidazoles; Kinins; Losartan; Male; Muscle, Smooth, Vascular; Oligopeptides; Ramipril; Rats; Rats, Inbred Strains; Tetrazoles | 1992 |
[Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Bridged Bicyclo Compounds; Calcium; Calcium Channel Blockers; Calcium Channels; Culture Techniques; Dose-Response Relationship, Drug; Gallic Acid; Muscle, Smooth, Vascular; Pyrroles; Ramipril; Rats; Verapamil | 1991 |
Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man.
Topics: Administration, Oral; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bridged Bicyclo Compounds; Female; Humans; Kidney Cortex; Male; Middle Aged; Myocardium; Peptidyl-Dipeptidase A; Ramipril; Reference Values; Renin; Surgical Procedures, Operative; Time Factors | 1991 |
Effects of ramipril on arterial hemodynamics.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteries; Blood Pressure; Blood Volume; Brachial Artery; Bridged Bicyclo Compounds; Carotid Arteries; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Vascular Resistance | 1991 |
Does converting enzyme inhibition change the neuronal and extraneuronal uptake of catecholamines?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Catecholamines; Corticosterone; Desipramine; Epinephrine; Heart; Myocardium; Norepinephrine; Ramipril; Rats; Rats, Inbred SHR; Tubocurarine; Vagotomy | 1991 |
Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Bridged Bicyclo Compounds; Cardiomegaly; Constriction; Hypertension; Imidazoles; Losartan; Male; Ramipril; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1991 |
Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood Volume; Bridged Bicyclo Compounds; Erythrocyte Count; Erythropoiesis; Erythropoietin; Hematocrit; Male; Ramipril; Rats; Rats, Inbred WKY; Renin; Reticulocytes | 1990 |
Converting enzyme inhibition in kinin-deficient brown Norway rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Kinins; Male; Ramipril; Rats; Rats, Inbred BN; Species Specificity | 1990 |
Roles of peripheral and central angiotensin-converting enzyme (ACE) in hypovolemic thirst induced by compound 48/80 in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Bridged Bicyclo Compounds; Drinking; Injections, Intraventricular; Male; p-Methoxy-N-methylphenethylamine; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Inbred Strains; Thirst | 1990 |
Vascular angiotensin conversion in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Forearm; Humans; Hypertension; Kinetics; Peptidyl-Dipeptidase A; Pyrroles; Ramipril; Reference Values; Regional Blood Flow; Renin | 1986 |
Converting enzyme inhibitors and brain angiotensin.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Enalaprilat; Kinetics; Male; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Inbred WKY | 1986 |
Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Creatinine; Female; Heart Rate; Humans; Kidney Diseases; Male; Middle Aged; Peptidyl-Dipeptidase A; Ramipril; Renin; Time Factors | 1989 |
Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Humans; Hypertension; Kallikreins; Kinins; Middle Aged; Proline; Radioimmunoassay; Ramipril; Renin; Sodium | 1989 |
Modulation of natriuresis by sympathetic nerves and angiotensin II in conscious dogs.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Carotid Arteries; Dogs; Glomerular Filtration Rate; Kidney; Natriuresis; Ramipril; Reference Values; Reflex; Renal Artery; Renin; Sympathetic Nervous System | 1989 |
Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bridged Bicyclo Compounds; Cardiomegaly; Dihydralazine; Hypertension; Male; Nifedipine; Ramipril; Rats; Rats, Inbred Strains | 1989 |
Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Bradykinin; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Diuresis; Heart Rate; Humans; Hypertension; Kallikreins; Kinins; Ramipril; Renin-Angiotensin System | 1989 |
Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Topics: Action Potentials; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Bradykinin; Bridged Bicyclo Compounds; Digoxin; Female; Guinea Pigs; Heart; In Vitro Techniques; Lidocaine; Male; Rabbits; Ramipril; Rats; Rats, Inbred Strains | 1989 |
Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Creatine Kinase; Heart; In Vitro Techniques; Indomethacin; Male; Myocardium; Norepinephrine; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Saralasin | 1989 |
Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Topics: Angiotensin I; Angiotensin II; Animals; Appetite; Brain; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Captopril; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Dose-Response Relationship, Drug; Drinking; Enalapril; Ramipril; Rats; Rats, Inbred Strains; Renin; Sodium Chloride | 1988 |
[Interaction of chronic inhibition of the angiotensin-converting enzyme and the sympathetic system: effect of added sodium chloride load].
Topics: Adrenal Glands; Angiotensin II; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Epinephrine; Hypertension; Male; Myocardium; Ramipril; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium, Dietary; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Water-Electrolyte Balance | 1988 |
Intrarenal generation of angiotensin II evaluated by an electrophysiological technique.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Bridged Bicyclo Compounds; Captopril; Female; Hydronephrosis; Juxtaglomerular Apparatus; Kidney; Membrane Potentials; Mice; Ramipril; Renin | 1987 |
Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
Topics: Adult; Aged; Angiotensin I; Angiotensin II; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Forearm; Humans; Middle Aged; Ramipril; Regional Blood Flow; Renin | 1987 |
Tissue renin-angiotensin systems: focus on the heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Heart; Macaca mulatta; Myocardium; Rabbits; Ramipril; Rats; Renin-Angiotensin System | 1987 |
[Effects of conversion enzyme inhibitors on the synthesis of angiotensin II by the isolated rat kidney].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bridged Bicyclo Compounds; Captopril; Kidney; Male; Ramipril; Rats; Rats, Inbred Strains | 1987 |
Measurement and characterization of angiotensin peptides in plasma.
Topics: Adult; Angiotensin I; Angiotensin II; Animals; Blood Specimen Collection; Bridged Bicyclo Compounds; Chromatography, High Pressure Liquid; Female; Humans; Iodine Radioisotopes; Male; Nephrectomy; Radioimmunoassay; Ramipril; Rats; Reference Values | 1988 |
Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Humans; Male; Ramipril; Renin | 1986 |
Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Enalapril; Hypertension; Indoles; Male; Perindopril; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renin-Angiotensin System | 1986 |
Ramipril for hypertension secondary to renal artery stenosis. Changes in blood pressure, the renin-angiotensin system and total and divided renal function.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Female; Glomerular Filtration Rate; Humans; Hypertension, Renovascular; Male; Middle Aged; Potassium; Ramipril; Renal Artery Obstruction; Renin-Angiotensin System | 1987 |
Heart and vascular wall as targets for tissue converting enzyme inhibition.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Vessels; Bradykinin; Bridged Bicyclo Compounds; Endothelium; Guinea Pigs; Heart; In Vitro Techniques; Muscle, Smooth, Vascular; Myocardium; Ramipril; Rats | 1987 |
Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Brain; Hypertension; Pyrroles; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spinal Cord | 1986 |
Effects of angiotensin II and ACE inhibitors on electrically stimulated noradrenaline release from superfused rat brain slices.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Bridged Bicyclo Compounds; Captopril; Clonidine; Dipeptides; Enalaprilat; In Vitro Techniques; Norepinephrine; Ramipril; Rats | 1984 |
Attenuation of cyclosporine A-induced vascular toxicity by ramipril.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Blood Pressure; Cyclosporine; Endothelium, Vascular; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phenylephrine; Ramipril; Rats; Rats, Wistar | 1994 |
Effects of ramipril on contractile oscillations in arteries from genetically hypertensive rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Age Factors; Angiotensin II; Animals; Aorta; Blood Pressure; Carotid Arteries; Hypertension; In Vitro Techniques; Indoles; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oscillometry; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction | 1994 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Enzyme Precursors; Enzyme Repression; Gene Expression Regulation, Enzymologic; Imidazoles; Indomethacin; Kidney; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles | 1995 |
Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diclofenac; Dogs; Electric Stimulation; Female; Norepinephrine; Perfusion; Prostaglandins; Ramipril; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1994 |
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog.
Topics: Adrenergic alpha-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Hemodynamics; Magnetic Resonance Imaging; Myocardium; Phenylephrine; Ramipril; Receptors, Angiotensin; Renin; Stress, Mechanical; Ventricular Function | 1994 |
Interrelation between renin mRNA levels, renin secretion, and blood pressure in two-kidney, one clip rats.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension, Renovascular; Male; Ramipril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1994 |
Converting enzyme inhibition and renal tissue angiotensin II in the rat.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enalapril; Kidney; Male; Radioimmunoassay; Ramipril; Rats; Rats, Sprague-Dawley | 1994 |
Renal 11 beta-hydroxysteroid dehydrogenase activity is enhanced by ramipril and captopril.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Corticosterone; Fasting; Hydroxysteroid Dehydrogenases; Kidney; Male; Ramipril; Rats; Rats, Sprague-Dawley; Tritium | 1994 |
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole | 1993 |
Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Heart Atria; Imidazoles; In Vitro Techniques; Kinetics; Losartan; Male; Myocardium; Norepinephrine; Ramipril; Receptors, Angiotensin; Tetrazoles | 1993 |
Dose-response differences in the ability of ramipril to improve retention in diabetic mice.
Topics: Angiotensin I; Angiotensin II; Animals; Avoidance Learning; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Male; Mice; Ramipril; Retention, Psychology | 1993 |
Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; Cell Division; Cells, Cultured; Collagen; DNA; Drug Synergism; Fibronectins; Gelatin; Imidazoles; Losartan; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Ramipril; Rats; Recombinant Proteins; Stress, Mechanical; Tetrazoles; Thymidine | 1993 |
Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cholesterol; Diet, Atherogenic; Dose-Response Relationship, Drug; Endothelium, Vascular; Hyperlipidemias; In Vitro Techniques; Male; Nitroglycerin; Phenylephrine; Rabbits; Ramipril; Vasodilation | 1993 |
Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Chromatography, High Pressure Liquid; Male; Nephrectomy; Peptides; Peptidyl-Dipeptidase A; Radioimmunoassay; Ramipril; Rats; Rats, Sprague-Dawley; Reference Values; Renin | 1993 |
Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Electrophysiology; Female; Hemodynamics; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Rabbits; Ramipril; Tetrazoles | 1993 |
Long-term effects of brief antihypertensive treatment on systolic blood pressure and vascular reactivity in young genetically hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Hydralazine; Hydrochlorothiazide; Hypertension; Linear Models; Muscle Contraction; Muscle, Smooth, Vascular; Ramipril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vascular Resistance | 1995 |
Nitric oxide and the depressor response to angiotensin blockade in hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Coarctation; Arginine; Biphenyl Compounds; Blood Pressure; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Vasoconstrictor Agents | 1996 |
Regulation of ANG II receptor in hypertension: role of ANG II.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Gene Expression; Hypertension; Imidazoles; Losartan; Male; Nephrectomy; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta | 1996 |
The urinary bladder angiotensin system: response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors.
Topics: Anesthesia; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chromatography, High Pressure Liquid; Enalaprilat; Male; Ramipril; Rats; Rats, Sprague-Dawley; Urinary Bladder | 1996 |
Pressor action of angiotensin I at the ventrolateral medulla: effect of selective angiotensin blockade.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Imidazoles; Losartan; Male; Medulla Oblongata; Microinjections; Peptide Fragments; Ramipril; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1996 |
Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Differential Threshold; Diuresis; Hemodynamics; Imidazoles; Losartan; Natriuresis; Nephrectomy; Potassium; Ramipril; Rats; Rats, Wistar; Renal Circulation; Tetrazoles; Vasodilation | 1995 |
Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arachidonic Acid; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Endothelium, Vascular; Female; Hypercholesterolemia; Iliac Artery; In Vitro Techniques; Indomethacin; Lipoxygenase Inhibitors; Male; Masoprocol; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Rabbits; Ramipril; Vasoconstrictor Agents | 1997 |
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 1997 |
[Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension, Renal; In Vitro Techniques; Kidney; Male; Ramipril; Rats; Rats, Inbred SHR; Renin; Time Factors | 1997 |
The arterial length-densities under preventive angiotensin-converting-enzyme inhibiting treatment in the myocardium of spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillaries; Coronary Vessels; Dose-Response Relationship, Drug; Hypertension; Myocardium; Neovascularization, Pathologic; Organ Size; Ramipril; Random Allocation; Rats; Rats, Inbred SHR; Vasoconstrictor Agents | 1998 |
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Heart Failure; Male; Myocardium; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; Statistics, Nonparametric; Tetrazoles; Valine; Valsartan | 1999 |
Renin-angiotensin system inhibitors as antihypertrophic agents.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2000 |
Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Disease Models, Animal; Gene Expression; In Situ Hybridization; Kidney; Macrophages; Male; Nephrectomy; Nephritis, Interstitial; Osteopontin; Ramipril; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Tetrazoles; Valine; Valsartan | 2000 |
Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiac Output; Chronic Disease; Echocardiography; Female; Heart; Heart Failure; Imidazoles; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Organ Size; Ramipril; Stroke Volume; Tetrazoles; Ventricular Remodeling | 2000 |
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Capillary Permeability; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Growth Factors; Gene Expression; In Situ Hybridization; Lymphokines; Male; Perindopril; Ramipril; Rats; Rats, Sprague-Dawley; Retina; Retinal Vessels; RNA, Messenger; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carotid Artery Injuries; Catheterization; Kidney Diseases; Losartan; Male; Peptidyl-Dipeptidase A; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents | 2001 |
Differential regulation of cathepsin B and prorenin gene expression in renal juxtaglomerular cells.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cathepsin B; Cell Line; Diet, Sodium-Restricted; Enzyme Induction; Enzyme Precursors; Gene Expression Regulation; Homeostasis; Juxtaglomerular Apparatus; Male; Mice; Ramipril; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; RNA, Messenger; Tetradecanoylphorbol Acetate; Water-Electrolyte Balance | 2001 |
Impaired angiotensin II regulation of renal C-type natriuretic peptide mRNA expression in experimental diabetes mellitus.
Topics: Angiotensin II; Animals; Blotting, Northern; Diabetes Mellitus, Experimental; Gene Expression Regulation; Kidney Cortex; Losartan; Male; Natriuretic Peptide, C-Type; Ramipril; Rats; Rats, Wistar; Renin-Angiotensin System; RNA, Messenger | 2001 |
Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; GTP-Binding Proteins; Hemodynamics; In Vitro Techniques; Kinins; Losartan; Male; Myocardial Contraction; Myocardium; Organ Size; Papillary Muscles; Protein Subunits; Pulmonary Artery; Rabbits; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Ventricular Dysfunction, Right | 2001 |
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Emotions; Heart Failure; Hemodynamics; Humans; Perindopril; Pulmonary Heart Disease; Quality of Life; Ramipril; Socioeconomic Factors; Surveys and Questionnaires; Tuberculosis, Pulmonary | 2001 |
Role of angiotensin II in dynamic renal blood flow autoregulation of the conscious dog.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dogs; Homeostasis; Ramipril; Renal Circulation; Vascular Resistance | 2002 |
Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Extremities; Femoral Artery; Gene Expression; Ischemia; Losartan; Male; Mice; Neovascularization, Physiologic; Peptidyl-Dipeptidase A; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Receptors, Bradykinin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction | 2002 |
Comparative effects of the dual ACE-NEP inhibitor MDL-100,240 and ramipril on hypertension and cardiovascular disease in endogenous angiotensin II-dependent hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Aorta; Benzazepines; Blood Pressure; Body Weight; Cardiovascular Diseases; Hypertension; In Vitro Techniques; Male; Neprilysin; Organ Size; Pyridines; Ramipril; Rats; Vasoconstriction | 2002 |
Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
Topics: Adrenomedullin; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Heart; Hypertension; Male; Models, Cardiovascular; Neprilysin; Organ Size; Peptides; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, Bradykinin; Severity of Illness Index; Systole; Treatment Outcome; Vasoconstrictor Agents | 2002 |
Angiotensin II and the fibroproliferative response to acute lung injury.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antibiotics, Antineoplastic; Antihypertensive Agents; Bleomycin; Cell Division; Cells, Cultured; Collagen; Fibroblasts; Humans; Losartan; Lung; Peptidyl-Dipeptidase A; Procollagen; Pulmonary Fibrosis; Ramipril; Renin-Angiotensin System; Transforming Growth Factor beta | 2004 |
Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cell Membrane; Gene Expression; Glucose; Hypertension, Renal; Immunoblotting; Kidney Cortex; Losartan; Male; Monosaccharide Transport Proteins; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Sodium; Sodium-Glucose Transporter 2 | 2004 |
The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.
Topics: Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Denervation; Dogs; Electric Stimulation; Homeostasis; Male; Ramipril; Stimulation, Chemical; Tetrazoles | 2004 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Diseases; Apolipoproteins E; Arteriosclerosis; Cell Line; Enzyme Induction; Eplerenone; Hormone Antagonists; Humans; Lipid Peroxidation; Lipoproteins, LDL; Losartan; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Peptidyl-Dipeptidase A; Phosphoproteins; Protein Transport; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Superoxides | 2004 |
Cardiac angiotensin is upregulated in the hearts of unstable angina patients.
Topics: Acute Disease; Angina Pectoris; Angina, Unstable; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Electrocardiography; Humans; Male; Middle Aged; Models, Cardiovascular; Myocardium; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2004 |
Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Blood Pressure; Diuresis; Gene Expression Regulation; Imidazoles; Kidney; Ligation; Losartan; Male; Nephrectomy; Proteinuria; Pyridines; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Renal Artery; RNA, Messenger | 2005 |
ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cell Line; Chemokine CCL2; Chemokines; Down-Regulation; Drug Interactions; Endothelium, Vascular; Humans; Imidazoles; Interleukin-8; Losartan; Monocytes; NF-kappa B; Peptidyl-Dipeptidase A; Pyridines; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Simvastatin; Umbilical Veins | 2004 |
Angiotensin I-converting enzyme-dependent and neutral endopeptidase-dependent generation and degradation of angiotensin II contrarily modulate noradrenaline release: implications for vasopeptidase-inhibitor therapy?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Dose-Response Relationship, Drug; Indans; Male; Neprilysin; Norepinephrine; Peptidyl-Dipeptidase A; Propionates; Protease Inhibitors; Pyridines; Ramipril; Rats; Rats, Inbred SHR; Thiazepines | 2005 |
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Pancreatitis; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 2006 |
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Corticosterone; Gene Expression Regulation; Hypothalamus; Male; Mibefradil; Pituitary-Adrenal System; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles | 2006 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Concanavalin A; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Intercellular Adhesion Molecule-1; Leukocyte Common Antigens; Leukostasis; Losartan; Male; Nifedipine; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ramipril; Rats; Rats, Long-Evans; Retina; Retinal Diseases | 2006 |
Effects of angiotensin II on connexin 43 of VSMCs in arteriosclerosis.
Topics: Angiotensin II; Animals; Arteriosclerosis; Body Weight; Cholesterol; Connexin 43; Losartan; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rabbits; Ramipril; RNA, Messenger | 2006 |
Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Topics: Actins; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cells, Cultured; Collagen; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Imidazoles; Myocardial Infarction; Myocytes, Cardiac; Neoplasm Proteins; Organ Size; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Ramipril; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2008 |
Decreased renal perfusion rapidly increases plasma membrane Na-K-ATPase in rat cortex by an angiotensin II-dependent mechanism.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biotin; Blood Pressure; Cell Membrane; In Vitro Techniques; Kidney Cortex; Male; Microsomes; Ramipril; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Renal Circulation; Renin; Sodium-Potassium-Exchanging ATPase | 2009 |
Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway.
Topics: Albumins; Angiotensin II; Cell Line; Down-Regulation; Drug Therapy, Combination; Endocytosis; Epithelial Cells; Everolimus; Humans; Immunosuppressive Agents; Kidney Tubules, Proximal; Losartan; Low Density Lipoprotein Receptor-Related Protein-2; Ramipril; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction; Sirolimus | 2010 |
Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arteries; Atherosclerosis; Immobilization; Losartan; Male; Nitric Oxide Synthase Type III; Oxidative Stress; Ramipril; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 2010 |
[Prevention of hypertension by drugs and immunization against angiotensin II].
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Vaccines | 2011 |
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2012 |
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Topics: Albuminuria; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progression; Down-Regulation; Fumarates; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Ramipril; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors | 2014 |
Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice.
Topics: Angiotensin II; Animals; Area Under Curve; Creatinine; Drinking; Energy Metabolism; Gene Expression Regulation; Glucose Tolerance Test; Homeostasis; Humans; Hypertension; Insulin; Insulin Secretion; Intra-Abdominal Fat; Kidney Function Tests; Kidney Tubules, Proximal; Mice, Inbred C57BL; Mice, Transgenic; Muscles; Organ Size; Phenotype; Ramipril; Renin-Angiotensin System | 2014 |
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Diterpenes; Ganglia, Spinal; Imidazoles; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pyridines; Ramipril; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Small Fiber Neuropathy; Substance P; Tetrazoles | 2017 |
Angiotensin converting enzyme inhibitor potentiates the hypoglycaemic effect of NG-nitro-L-arginine methyl ester (L-NAME) in rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Hypertension; Hypoglycemic Agents; Insulins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Prostaglandins I; Ramipril; Rats; Rats, Wistar | 2022 |
Primary Aldosteronism: The Next Decade.
Topics: Aldosterone; Angiotensin II; Humans; Hyperaldosteronism; Hypertension; Ramipril; Renin | 2020 |
Evaluation of Dual Inhibitory Effect of Anagliptin, Ramipril and Lisinopril on Angiotensin-Converting Enzyme and DPP-4 Activities.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Lisinopril; Pyrimidines; Ramipril; Rats; Rats, Sprague-Dawley | 2022 |
Effect of pharmacological heart failure drugs and gene therapy on Danon's cardiomyopathy.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Genetic Therapy; Glycogen Storage Disease Type IIb; Heart Failure; Humans; Mice; Ramipril; Reactive Oxygen Species; Spironolactone | 2023 |